David Daikh - Concepedia

Author

David Daikh

Also Known As

D Daikh, D I Daikh, D. Daikh, D. I. DAIKH, D. I. Daikh, D.I Daikh, DAVID I. DAIKH, Daikh, David Ismet, David Daikh, David I Daikh

107

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco San Francisco VA Medical Center Charité - Universitätsmedizin Berlin Technische Universität Dresden University of Michigan

About

David Daikh is an author at University of California, San Francisco specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2K
2	Immunology	7	7	493
3	Cell Biology	2	2	261
4	Health Sciences	1	1	79
5	Hepatology	1	1	11

David Daikh

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Martin Aringer, Karen H. Costenbader, David Daikh, Arthritis & Rheumatology	2019	2.3K
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Bevra H. Hahn, Maureen McMahon, Alan Wilkinson, Arthritis Care & Research Glomerular DiseaseRheumatology GuidelinesRenal PathologyPulse GlucocorticoidsUnited States	2012	1.5K
Idiopathic Nonspecific Interstitial Pneumonia Brent W. Kinder, Harold R. Collard, Laura L. Koth, American Journal of Respiratory and Critical Care Medicine	2007	367
Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells Kenneth J. Scalapino, Qizhi Tang, Jeffrey A. Bluestone, The Journal of Immunology	2006	255
An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity Ravindra Majeti, Zheng Xu, Tristram G. Parslow, Cell ImmunogeneticsInhibitory WedgeAutoimmune DiseaseInactivating Point MutationImmunology	2000	249
Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways David Daikh, Brian N. Finck, P S Linsley, The Journal of Immunology	1997	218
Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide David Daikh, David Wofsy The Journal of Immunology	2001	205
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus Frances Rena Bahjat, Polly Pine, Andrea Reitsma, Arthritis & Rheumatism	2008	172
A randomized trial of stress management for the prevention of new brain lesions in MS David C. Mohr, Jesús Lovera, Ted Brown, Neurology	2012	138
Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis Gaye Cunnane, Martha L. Warnock, Kenneth H. Fye, Arthritis Care & Research InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseVasculitis	2002	116

Page 1